Point72 (DIFC)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13K Buy
+99
New +$11.9K ﹤0.01% 918
2025
Q2
Sell
-1,834
Closed -$228K 1838
2025
Q1
$228K Sell
1,834
-3,340
-65% -$436K 0.01% 859
2024
Q4
$637K Buy
+5,174
New +$610K 0.02% 581
2024
Q3
Sell
-17,077
Closed -$1.82M 1644
2024
Q2
$1.82M Buy
+17,077
New +$1.88M 0.06% 358

Other funds holding JAZZ

Point72 (DIFC)'s JAZZ Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2025: 99 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #918 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in JAZZ as recently as Q1 2025.

Point72 (DIFC) first reported a position in JAZZ in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.82M in Q2 2024. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Point72 (DIFC) held 99 shares of Jazz Pharmaceuticals worth $13K as of Q3 2025.
  • Jazz Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • Jazz Pharmaceuticals made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #918 holding.
  • Point72 (DIFC) first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Jazz Pharmaceuticals position peaked at $1.82M in Q2 2024.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.